( 01 )Company + investment
Built to scale
One data core.
Many routes to market.
Medeagle Limited is developing technology across provider discovery, treatment extraction, pricing intelligence, AI-assisted content systems, search architecture and patient navigation.
Pre-revenue and raising a further £250,000 at a £3.8m pre-money valuation. Backed by the Google Startup Programme, Innovate UK support and a medical investment syndicate.
Supported byGoogle for StartupsInnovate UKMedical investment syndicate
( 02 )Our viewpoint
The connection problem
Patients struggle to compare. Providers struggle to be discovered.
The shortest path to care starts with connected data. Medeagle builds the intelligence layer that brings both sides together.
Understand intent
Capture the language, questions and signals that reveal what patients are really trying to find.
Structure providers
Make treatment, location, pricing and availability data consistent, connected and reusable.
Move people forward
Turn structured intelligence into search, comparison and enquiry experiences that work.
( 03 )What Medeagle does
One connected technology layer
From search signal
to provider growth.
A shared data foundation that can power consumer marketplaces, provider products, commercial intelligence, partner fulfilment and—where the evidence supports it—selective ownership.
01 Core practice
Understand what patients need
Demand intelligence
Turn search behaviour, questions and treatment intent into a live picture of medical consumer demand.↗
02 In motion
Structure the supply of care
Provider data graph
Connect treatments, providers, locations, pricing and availability in one reusable intelligence layer.↗
03 Live pathway
Create the connection
Marketplace conversion
Power search, comparison, booking and partner routing that move people towards the right provider.↗
● One data foundation. Multiple ways to connect patients and providers.
We’re our own first customer — proving the data
FastTrack Treatment is Medeagle’s live proving ground. Medeagle provides the structured provider data; FastTrack turns it into a consumer marketplace. Patient searches create fresh demand signals that feed back into the data core, improving the next comparison and the next match.
01SearchCapture patient intent→02CompareMatch structured supply→03BookLearn from conversion
Scroll to understand
( 05 )Launch tour + partner offer
See the marketplace in motion
From patient need
to provider opportunity.
A practical tour of FastTrack Treatment—how patients discover and compare treatment, how providers connect with active demand, and how Medeagle structures the intelligence underneath.
FastTrack TreatmentFilm / 01
( 06 )The investment case
Why nowIndependent market signals
The timing
The market is moving before it can be compared.
Demand is visible. Supply is growing. The information between them is still fragmented.
NHS pathways waiting
Sustained elective-care pressure is changing how people explore access to treatment.
Source / NHS England ↗Private admissions
UK private hospital admissions reached a fourth consecutive annual record in 2025.
Source / PHIN ↗Active consultants
A record private-sector consultant base creates a broad, fragmented supply universe.
Source / PHIN ↗EvidenceBuilt / live / backed
Evidence before forecast
This is already in motion.
The forecast starts from a working marketplace, a connected data foundation and institutional support—not a blank proposition.
Next proof layer / verified provider coverage · pricing records · marketplace enquiries
Use of funds12–18 month execution window
The next chapter
Capital turns the foundation into a repeatable engine.
£250kCurrent raise
Coverage
Expand and verify the provider and treatment universe.
Automation
Increase extraction, pricing and availability intelligence.
Distribution
Grow provider adoption and patient discovery.
Milestone-led deployment—not a detailed public budget.Outcome / measurable marketplace engine →
TeamRight to execute
The people behind the graph
Built across both sides of the market.
Commercial marketplace leadership, clinical context and data engineering combine around one execution plan.
Founder-led
Marketplace + commercialProduct direction, provider proposition, partnerships and capital strategy.
Clinical advisory
Care pathways + trustClinical relevance, provider credibility and responsible patient navigation.
Data + engineering
Graph + automationEntity architecture, extraction systems and reusable marketplace intelligence.
04 / Fulfilment layer Staged upside / not in the base case
Discovery reveals the opportunity. Fulfilment captures more of it.
The graph shows where demand, constrained access and attractive economics meet. Start with partners; deepen participation only where the evidence is clear.
01Prove demandIdentify persistent patient intent.→
02Route to partnersMove bookings to trusted capacity.→
03Learn economicsObserve price, conversion and outcomes.→
04Fulfil selectivelyOwn only proven pathways.
Route the booking
The provider delivers care; FastTrack participates through transaction or commission economics.
Own the proven pathway
Launch, operate or acquire capacity only where demand and unit economics have been evidenced.
Illustrative pathwaysSame-day GPOnline GPADHD diagnosisSexual-health home testing
↺ Fulfilment outcomes, pricing and conversion strengthen the graph.
The base case stands before fulfilment.
The provider marketplace and data/software layer form the modelled core. Partnered and owned fulfilment remain staged upside until live pathways validate their economics.
Modelled
core
core
Provider marketplaceSubscription and platform revenue
Modelled
core
core
Data + softwareReusable intelligence products
Staged
upside
upside
Partner fulfilmentTransaction and commission economics
Staged
upside
upside
Selective ownershipOperate or acquire proven pathways
Fulfilment revenue remains outside the published base case pending funded unit-economics validation.
( 07 )Illustrative commercial model
Significant outcome / modest captureFive-year base scenario
The commercial trajectory
The model scales before
the market saturates.
An eight-figure base case from a low-single-digit share of the addressable provider market—shown at headline level, with the commercial mechanics held for diligence.
£15m+Modelled annual revenue
by year five
by year five
Y1BuildY2ProveY3ValidateY4EBITDA +Y5Scale
3,000+Providers in network
<4%Provider market share
Y4EBITDA positive
High-90sModelled gross margin
Illustrative management model—subject to validation and diligence refinement. Headline ranges shown; underlying assumptions available on request. Partnered and owned fulfilment revenue is excluded pending funded unit-economics validation.